BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $106 at Credit Suisse
Get Alerts BMRN Hot Sheet
Price: $87.34 -1.43%
Rating Summary:
22 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
22 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $106.00 (from $105.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Teleperformance (TEP:FP) (TLPFY) PT Lowered to EUR125 at RBC Capital, 'perceived risk profile makes it a no-fly zone for many investors'
- Hyundai Motor (005380:KS) (HYMTF) PT Raised to KRW290 at Citi
- MAG Silver (MAG:CN) (MAG) PT Lowered to Cdn$19.50 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!